Changes in market conditions had adversely affected Bio Clinic’s earnings. In order to achieve its budgeted profitability targets, the company began capitalizing operating expenses (i.e., instead of debiting an expense account, asset accounts were debited). The asset accounts used were accounts receivable and property and equipment. This practice created discrepancies between the general ledger balances of these accounts and their respective subsidiary ledger balances. To avoid detection, management artificially increased the total on the last page of the accounts receivable subsidiary ledger to match the balance in the general ledger (note that if the individual customer account balances in the subsidiary ledger had been totaled, this fraud might have been detected).